ABCD3 and prostate neoplasm: Statistically, the mean expression of ABCD3 was significantly associated with age at ≤ 67 (P = 0.0014), with well-to-moderately and poorly differentiated prostate tumors (P = 0.0009), and with Gleason score of ≤6 (P = 0.0094).